Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery
Healthcare IT Today
SEPTEMBER 9, 2024
Investors in the $180 million round include Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, Aescuvest, Optum Ventures, Cure Capital, Relyens Group, Vesalius Biocapital, Lauxera Capital, Plug & Play Growth Fund, and ProAssurance Corp.
Let's personalize your content